Congenital Muscular Dystrophy due to Novel Compound Heterozygote Mutations in POMGNT1 Gene

scientific article published on 01 October 2018

Congenital Muscular Dystrophy due to Novel Compound Heterozygote Mutations in POMGNT1 Gene is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.4103/JPN.JPN_36_18
P932PMC publication ID6413589
P698PubMed publication ID30937090

P2093author name stringSedat Işıkay
Akif Şirikçi
P2860cites workPrimary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixQ28296676
Dystroglycanopathies: coming into focusQ37852376
Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencingQ38647928
Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.Q38924048
Golgi phosphoprotein 3 mediates the Golgi localization and function of protein O-linked mannose β-1,2-N-acetlyglucosaminyltransferase 1.Q39886001
Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophiesQ42524150
Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathiesQ48348730
Dystroglycanopathies: About Numerous Genes Involved in Glycosylation of One Single GlycoproteinQ48395145
Muscular dystrophiesQ86291937
P433issue4
P921main subjectcongenital muscular dystrophyQ1321884
P304page(s)462-464
P577publication date2018-10-01
P1433published inJournal of Pediatric NeurosciencesQ6295723
P1476titleCongenital Muscular Dystrophy due to Novel Compound Heterozygote Mutations in POMGNT1 Gene
P478volume13

Search more.